Abstract
Dementia has become a major health concern for the aging population of the United States. Studies indicate that participation in moderate exercise, with training, has been shown to have a beneficial impact on cognition. Thus, exercise and its effects on cognitive function has become an important area of research. This review summarizes the current literature on the potential mechanisms of the benefits of exercise for cognitive function.
Keywords: Cognitive function, dementia, exercise, BDNF, PGC-1α, IL-6.
Current Pharmaceutical Design
Title:The Potential Mechanisms of Exercise-induced Cognitive Protection: A Literature Review
Volume: 24 Issue: 17
Author(s): Jennifer E. Norman*, Jennifer Rutkowsky, Sue Bodine and John C. Rutledge
Affiliation:
- Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, CA,United States
Keywords: Cognitive function, dementia, exercise, BDNF, PGC-1α, IL-6.
Abstract: Dementia has become a major health concern for the aging population of the United States. Studies indicate that participation in moderate exercise, with training, has been shown to have a beneficial impact on cognition. Thus, exercise and its effects on cognitive function has become an important area of research. This review summarizes the current literature on the potential mechanisms of the benefits of exercise for cognitive function.
Export Options
About this article
Cite this article as:
Norman E. Jennifer *, Rutkowsky Jennifer , Bodine Sue and Rutledge C. John, The Potential Mechanisms of Exercise-induced Cognitive Protection: A Literature Review, Current Pharmaceutical Design 2018; 24 (17) . https://dx.doi.org/10.2174/1381612824666180406105149
DOI https://dx.doi.org/10.2174/1381612824666180406105149 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Mini-Mental Parkinson’s (MMP) as a Cognitive Screening Tool in People with Parkinson’s Disease
Current Aging Science Spirocyclohexadienones as an Uncommon Scaffold for Acetylcholinesterase Inhibitory Activity
Medicinal Chemistry Metals and Parkinson's Disease: Mechanisms and Biochemical Processes
Current Medicinal Chemistry Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Animal Models for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer Research Editorial (Thematic Issue: Mitochondria and Subcellular Organelles as Treatment Targets Against Pathological Conditions)
Current Pharmaceutical Design Treating Hypertension in the Elderly: Common Problems and Solutions
Current Hypertension Reviews A1 Receptors Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Identification and Detection of Transmissible Spongiform Encephalopathies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Psychological Problems in Female Fragile X Premutations Carriers
Current Psychiatry Reviews FDG-PET Studies of Semantic Dementia; A Review
Current Molecular Imaging (Discontinued) Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease
Current Alzheimer Research Microglial dependent protective effects of neuroactive steroids
CNS & Neurological Disorders - Drug Targets Platelets and Platelet Interaction with Progenitor Cells in Vascular Homeostasis and Inflammation
Current Vascular Pharmacology Stem Cells in Stroke Repair: Current Success & Future Prospects
CNS & Neurological Disorders - Drug Targets Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
Current Drug Targets Selective Neuronal Nitric Oxide Synthase Inhibitors
Current Topics in Medicinal Chemistry Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Current Pharmaceutical Design Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)